Friday, July 10, 2026

pharma · Cystic Adenomatoid Malformation of Lung, Congenital

Lei Xiaoming

Lei Xiaoming clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Lei Xiaoming projects

1 ClinicalTrials.gov programs sponsored by Lei Xiaoming.

Lei Xiaoming has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Ropivacaine

    Lei Xiaoming

    Cystic Adenomatoid Malformation of Lung, Congenital

    small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Lei Xiaoming have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.